Macroaxis considers BHARAT IMMUNOLOGICALS to be very risky. BHARAT IMMUNOLOGICALS retains Efficiency (Sharpe Ratio) of -0.0302 which signifies that the organization had -0.0302% of return per unit of risk over the last 2 months. Macroaxis approach to foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. BHARAT IMMUNOLOGICALS exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm BHARAT IMMUNOLOGICALS BIOLOG Market Risk Adjusted Performance of
(0.21) and Coefficient Of Variation of (1,406) to double-check risk estimate we provide.
60 Days Market Risk
Chance of Distress in 24 months
60 Days Economic Sensitivity
Actively responds to market
|Horizon||30 Days Login to change|
BHARAT IMMUNOLOGICALS Market Sensitivity
|As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, BHARAT IMMUNOLOGICALS will likely underperform. 2 Months Beta |Analyze BHARAT IMMUNOLOGICALS Demand TrendCheck current 30 days BHARAT IMMUNOLOGICALS correlation with market (DOW)|
β = 1.609
BHARAT IMMUNOLOGICALS Central Daily Price Deviation
BHARAT IMMUNOLOGICALS Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
BHARAT IMMUNOLOGICALS Projected Return Density Against MarketAssuming 30 trading days horizon, the stock has beta coefficient of 1.609 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average . However, if the benchmark returns are expected to be negative, BHARAT IMMUNOLOGICALS will likely underperform. Additionally, The company has a negative alpha implying that the risk taken by holding this equity is not justified. BHARAT IMMUNOLOGICALS is significantly underperforming DOW.
Predicted Return Density
Assuming 30 trading days horizon, the coefficient of variation of BHARAT IMMUNOLOGICALS is -3305.82. The daily returns are destributed with a variance of 18.82 and standard deviation of 4.34. The mean deviation of BHARAT IMMUNOLOGICALS BIOLOG is currently at 3.02. For similar time horizon, the selected benchmark (DOW) has volatility of 0.92
|Alpha over DOW||=||0.27|
|Beta against DOW||=||1.61|
BHARAT IMMUNOLOGICALS Return Volatilitythe company accepts 4.3387% volatility on return distribution over the 30 days horizon. the entity inherits 0.9282% risk (volatility on return distribution) over the 30 days horizon.
BHARAT IMMUNOLOGICALS Investment Opportunity
BHARAT IMMUNOLOGICALS BIOLOG has a volatility of 4.34 and is 4.67 times more volatile than DOW. 38% of all equities and portfolios are less risky than BHARAT IMMUNOLOGICALS. Compared to the overall equity markets, volatility of historical daily returns of BHARAT IMMUNOLOGICALS BIOLOG is lower than 38 (%) of all global equities and portfolios over the last 30 days. Use BHARAT IMMUNOLOGICALS BIOLOG to protect your portfolios against small markets fluctuations. The stock experiences very speculative upward sentiment. Check odds of BHARAT IMMUNOLOGICALS to be traded at 6.18 in 30 days. . As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, BHARAT IMMUNOLOGICALS will likely underperform.
BHARAT IMMUNOLOGICALS correlation with market
BHARAT IMMUNOLOGICALS Current Risk Indicators
|Risk Adjusted Performance||(0.06)|
|Market Risk Adjusted Performance||(0.21)|
|Coefficient Of Variation||(1,406)|
BHARAT IMMUNOLOGICALS Suggested Diversification Pairs